We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Rheumatology

Journal Scan / Research · October 13, 2021

Anti-TNF Treatment for the Prevention of Ischemic Events in Patients With DADA2

Rheumatology (Oxford, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Rheumatology (Oxford, England)
Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2)
Rheumatology (Oxford) 2021 Sep 01;60(9)4373-4378, S Cooray, E Omyinmi, Y Hong, C Papadopoulou, L Harper, E Al-Abadi, R Goel, S Dubey, M Wood, S Jolles, S Berg, M Ekelund, K Armon, D Eleftheriou, PA Brogan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading